Skip to main content

Table 4 Intensity of adverse events reported as being related to the investigational product

From: Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria

AE intensity/type One intake N = 161 Two intakes N = 155
Mild Moderate Severe Mild Moderate Severe
Gastrointestinal 1 4 0 2 1 0
Abdominal pain 0 2 0 0 1 0
Duodenal ulcer 0 1 0 0 0 0
Nausea 1 1 0 2 0 0
Nervous system 0 0 1 3 0 0
Dysgeusia 0 0 0 1 0 0
Drowsiness 0 0 0 2 0 0
Seizures 0 0 1 0 0 0
Skin 4 1 0 2 1 0
Pruritus 3 0 0 0 1 0
Generalized pruritus 1 1 0 2 0 0
Total 5 5 1 7 2 0